Literature DB >> 15943830

Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism.

Dorte Glintborg1, Marianne Andersen, Claus Hagen, Anne Pernille Hermann.   

Abstract

OBJECTIVE: The mechanisms leading to higher bone mineral density (BMD) in hirsute patients than in healthy controls have seldom been examined. We compared the metabolic, hormonal and bone metabolic parameters in hirsute patients and female controls and correlated BMD and bone metabolic parameters with testosterone, oestradiol and metabolic parameters. PATIENTS: Fifty-one Caucasian, reproductive-aged, hirsute patients referred to the outpatient clinic of an academic tertiary-care medical centre and 63 healthy, female Caucasian controls matched for season, weight and age. MEASUREMENTS: BMD (hip, neck, lumbar and total BMD), bone metabolic parameters (osteocalcin, alkaline phosphatase, PTH, ionized calcium, phosphate and 25-hydroxyvitamin D (25OHD)) and endocrine profiles (androgen status, oestradiol and insulin) were evaluated during follicular phase. Oestradiol measurement was repeated during cycle days 8-12.
RESULTS: Lumbar and neck BMD levels were significantly higher in hirsute patients than in controls: (mean +/- SD): lumbar BMD 1.10 +/- 0.12 vs. 1.06 +/- 0.10 g/cm2 and neck BMD 0.91 +/- 0.11 vs. 0.87 +/- 0.12 g/cm2, P < 0.05. Fasting insulin and free testosterone levels were significantly higher in hirsute patients than in controls. Free testosterone correlated positively with neck and hip BMD levels in hirsute patients. During multiple regression analysis, testosterone, oestradiol and waist/hip ratio (WHR) were found to have positive effects on BMD levels independent of body mass index (BMI). 25OHD levels were significantly lower in hirsute patients [42 (13-131)] than in controls [72 (27-196)] nmol/l (geometric mean +/- 2SD), P < 0.001].
CONCLUSION: Hirsute patients demonstrated significantly higher bone mineral density levels than controls, which could be explained by hyperinsulinaemia and higher testosterone levels in hirsute patients compared with controls. The pathogenesis for significantly lower 25-hydroxyvitamin D levels in hirsute patients compared with controls needs to be evaluated in future studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943830     DOI: 10.1111/j.1365-2265.2005.02280.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.

Authors:  Jana Figurová; Ingrid Dravecká; Martin Javorský; Jana Petríková; Ivica Lazúrová
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

2.  Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.

Authors:  Camila F Pereira-Eshraghi; Codruta Chiuzan; Yuan Zhang; Rachel H Tao; Matthew McCann; Y Dana Neugut; Alison Printz; Ilene Fennoy; Melanie Cree-Green; Sharon E Oberfield; Aviva B Sopher
Journal:  Horm Res Paediatr       Date:  2020-04-29       Impact factor: 2.852

3.  Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.

Authors:  Dorte Glintborg; Hanne Mumm; Magda Lambaa Altinok; Bjørn Richelsen; Jens Meldgaard Bruun; Marianne Andersen
Journal:  J Endocrinol Invest       Date:  2014-06-07       Impact factor: 4.256

4.  Vitamin D receptor gene polymorphisms and sex steroid secretion in girls with precocious pubarche in Southern Brazil: a pilot study.

Authors:  B R Santos; L P G Mascarenhas; F Satler; M C S Boguszewski; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2011-10-03       Impact factor: 4.256

5.  Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

Authors:  D Glintborg; A P Hermann; L M Rasmussen; M Andersen
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

6.  A preliminary investigation into the potential role of waist hip ratio (WHR) preference within the assortative mating hypothesis of autistic spectrum disorders.

Authors:  Mark Brosnan; Ian Walker
Journal:  J Autism Dev Disord       Date:  2008-07-04

7.  Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.

Authors:  Jenny L Wilson; Weiyi Chen; Gregory A Dissen; Sergio R Ojeda; Michael A Cowley; Cecilia Garcia-Rudaz; Pablo J Enriori
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.